Location: New York, NY
CIK: 0001633313 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 14, 2023
Total Value: $7.371B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APLS | APELLIS PHARMACEUTICALS INC | 11,111,111 | $1.012B | 13.7% | $48.71 | +77.1% | Common | 03753U106 |
| — | HORIZON THERAPEUTICS PLC | 7,000,000 | $720M | 9.8% | $66.26 | — | Common | G46188101 |
| UTHR | UNITED THERAPEUTICS CORP | 2,909,999 | $642M | 8.7% | $134.94 | +64.1% | Common | 91307C102 |
| SRPT | SAREPTA THERAPEUTICS INC | 4,627,888 | $530M | 7.2% | $107.25 | +20.1% | Common | 803607100 |
| ARGX | ARGENX SE | 1,263,500 | $492M | 6.7% | $140.84 | — | Sponsored ADR | 04016X101 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 1,515,151 | $350M | 4.7% | $118.73 | +128.1% | Common | 558868105 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 4,000,000 | $347M | 4.7% | $85.74 | +9.8% | Common | 09061G101 |
| FOLD | AMICUS THERAPEUTICS INC | 27,400,000 | $344M | 4.7% | $10.47 | +13.4% | Common | 03152W109 |
| — | SEAGEN INC | 1,759,606 | $339M | 4.6% | $146.25 | — | Common | 81181C104 |
| ASND | ASCENDIS PHARMA | 3,580,555 | $320M | 4.3% | $120.84 | — | Sponsored ADR | 04351P101 |
| — | IVERIC BIO INC | 8,050,000 | $317M | 4.3% | $13.10 | — | Common | 46583P102 |
| KRYS | KRYSTAL BIOTECH INC | 2,560,811 | $301M | 4.1% | $77.73 | +31.4% | Common | 501147102 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 1,105,000 | $210M | 2.8% | $153.75 | +28.9% | Common | 02043Q107 |
| — | MIRATI THERAPEUTICS INC | 5,555,555 | $201M | 2.7% | $53.82 | — | Common | 60468T105 |
| XENE | XENON PHARMACEUTICALS INC | 4,900,000 | $189M | 2.6% | $16.29 | +144.0% | Common | 98420N105 |
| — | CYMABAY THERAPEUTICS INC | 10,300,000 | $113M | 1.5% | $6.26 | — | Common | 23257D103 |
| — | DICE THERAPEUTICS INC | 2,199,342 | $102M | 1.4% | $28.94 | — | Common | 23345J104 |
| KYMR | KYMERA THERAPEUTICS INC | 3,855,000 | $88.63M | 1.2% | $31.77 | -9.8% | Common | 501575104 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 1,725,000 | $87.97M | 1.2% | $26.91 | 0.0% | CLASS A ORD | 61559X104 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 12,055,000 | $84.87M | 1.2% | $11.36 | -29.3% | Common | 09058V103 |
| NUVL | NUVALENT INC | 1,600,000 | $67.47M | 0.9% | $28.81 | +31.2% | Common | 670703107 |
| ROIV | ROIVANT SCIENCES LTD | 5,806,162 | $58.53M | 0.8% | $8.94 | 0.0% | Common | G76279101 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 2,650,000 | $55.46M | 0.8% | $21.05 | -1.1% | Common | 87164F105 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 6,700,000 | $47.17M | 0.6% | $16.40 | -56.4% | Common | 462260100 |
| MNKD | MANNKIND CORP | 9,100,000 | $37.04M | 0.5% | $3.56 | +17.3% | Common | 56400P706 |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 750,000 | $34.6M | 0.5% | $64.00 | -27.5% | Common | 90400D108 |
| — | MARINUS PHARMACEUTICALS INC | 3,150,000 | $34.21M | 0.5% | $12.20 | — | Common | 56854Q200 |
| KURA | KURA ONCOLOGY INC | 3,105,000 | $32.85M | 0.4% | $23.38 | -49.4% | Common | 50127T109 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 4,535,000 | $31.06M | 0.4% | $17.04 | -62.1% | Common | 61225M102 |
| RNAM | AVIDITY BIOSCIENCES INC | 2,510,000 | $27.84M | 0.4% | $21.47 | -41.6% | Common | 05370A108 |
| DSGN | DESIGN THERAPEUTICS INC | 3,500,000 | $22.05M | 0.3% | $19.27 | -68.2% | Common | 25056L103 |
| — | MERSANA THERAPEUTICS INC | 6,375,000 | $20.97M | 0.3% | $21.34 | — | Common | 59045L106 |
| WHWK | AADI BIOSCIENCES INC | 2,849,402 | $19.49M | 0.3% | $24.27 | -68.0% | Common | 00032Q104 |
| PMVP | PMV PHARMACEUTICALS INC | 3,060,000 | $19.16M | 0.3% | $25.09 | -79.1% | Common | 69353Y103 |
| — | VERRICA PHARMACEUTICALS INC | 2,954,064 | $17.04M | 0.2% | $6.42 | — | Common | 92511W108 |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 357,403 | $12.74M | 0.2% | $34.48 | 0.0% | Common | 04280A100 |
| — | SERES THERAPEUTICS INC | 2,500,000 | $11.97M | 0.2% | $5.25 | — | Common | 81750R102 |
| — | IKENA ONCOLOGY INC | 1,640,000 | $10.76M | 0.1% | $6.56 | — | Common | 45175G108 |
| FENC | FENNEC PHARMACEUTICALS INC | 1,200,000 | $10.6M | 0.1% | $9.85 | -15.6% | Common | 31447P100 |
| TNGX | TANGO THERAPEUTICS INC | 1,640,000 | $5.445M | 0.1% | $11.71 | -69.3% | Common | 87583X109 |
| IOBT | IO BIOTECH INC | 2,055,883 | $4.03M | 0.1% | $9.66 | -79.8% | Common | 449778109 |
| — | TALARIS THERAPEUTICS INC | 500,000 | $1.52M | 0.0% | $3.04 | — | Common | 87410C104 |
| — | AEGLEA BIOTHERAPEUTICS INC | 286,459 | $129K | 0.0% | $0.45 | — | Common | 00773J103 |